We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

API R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 1-3, Kuise Terajima 2-Chome, Amagasaki, Hyogo 660-0813, Japan ...

Shionogi & Co. Ltd. (4507.TO) Osaka Year Ended March 31 GROUP 2025 2024 Revenue Y438.27 bln Y435.08 bln Operating Profit Y156.60 bln Y153.31 bln Pretax Profit Y200.75 bln Y198.28 bln Net Profit ...

Shionogi & Co., Ltd. stock price live, this page displays TYO 4507 stock exchange ... Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral ...

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant ...

TOKYO -- Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO Christophe Weber said Thursday, with the money going toward both manufacturing ...

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Dr. Gomez is Chief Medical Officer of Shionogi & Co., Ltd., a Pharmaceutical Company with Headquarters in Osaka, Japan, that is focused on the development of innovative treatments for infectious ...

Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to expand its global R&D business. The two ...

Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 billion, buying the pharmaceutical operations of Japan Tobacco, including its US ...